MGC Pharmaceuticals has signed a deal to distribute cannabis-based pharmaceutical products throughout Europe and to produce and cultivate medical cannabis in Malta.
The Australian company made the distribution agreement with AM Mangion, a Maltese company specialising in the distribution of products in the medical sector.
MGC will supply an “initial range” of products which AM Mangion will distribute through Malta, Italy, France, Spain, Portugal and the UK – and also in the Middle East and North Africa.
Other products will be included for distribution on an agreed ad hoc basis, MGC said.
...
Restricted content. Do you want to read more?
Register
Sign up NOW for 7 days FREE TRIAL and access our briefings section
This report will enable you to identify pricing differences and the range of pricing for product types across different markets, understand possible reasoning for pricing differences across different markets, and identify price points for strategy development and price setting.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.
